About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Active campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives

Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

About us
About the Access Campaign

Our 2022 wishlist

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Active campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives

Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

WHO Executive Board's Special Session on Ebola

Events |

29 January 2019

MSF statements at WHO Executive Board 144th session

UN Photo/Christopher Black

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

MSF representatives are attending the 144^th session of the WHO executive board meetings and will be speaking on a number of topics.

Our statements

Statement |

31 January 2019

Drug-resistant infections

144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance

2 min

Statement |

29 January 2019

Research and development

144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines

2 min

Statement |

29 January 2019

Research and development

144th WHO EB: Medicines, vaccines and health products: Cancer medicines

2 min

Statement |

30 January 2019

144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis

2 min

Read, watch, share

Statement |

03 February 2020

Tropical & neglected diseases

WHO 146th EB -13 (EB146/14) – Neglected tropical diseases

2 min

Glucometer, syringes and test strips for patients with diabetes

Photograph by Paul Odongo

Press release |

23 May 2022

Diabetes

Towards insulin for all: Operationalising the WHA74 resolution on diabetes

2 min

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Events |

01 February 2022

MSF 150th EB Statement about non-State actors in WHO’s governing system

2 min

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Events

Events |

24 January 2022

MSF statement at WHO Executive Board 150th Session

2 min